Home/Filings/4/0001753939-19-000001
4//SEC Filing

Teague Robert Eric 4

Accession 0001753939-19-000001

CIK 0000737207other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 4:26 PM ET

Size

5.7 KB

Accession

0001753939-19-000001

Insider Transaction Report

Form 4
Period: 2019-01-15
Teague Robert Eric
Chief Financial Officer
Transactions
  • Award

    Options to purchase common stock

    2019-01-15+100,000100,000 total
    Exercise: $0.32Exp: 2029-01-15common stock (100,000 underlying)
Footnotes (1)
  • [F1]Options to purchase 25,000 shares of common stock are exercisable immediately, and options to purchase 25,000 shares of common stock shall vest on each of the one, two and three year anniversaries of the grant date.

Issuer

Adhera Therapeutics, Inc.

CIK 0000737207

Entity typeother

Related Parties

1
  • filerCIK 0001753939

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:26 PM ET
Size
5.7 KB